ARCHIVES

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997

Panel Calls For New Office, Advisory Groups To Oversee NCI’s Translational Research.

June 22, 2007

Group Chairman Present A Counter-Proposal To NCI Committee

June 12, 1998

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014